Copper to zinc ratio in kidney failure patients
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial checks if the balance of copper and zinc in your blood affects health outcomes for people with end-stage kidney disease on dialysis. It does not test a new drug, but may help doctors understand your condition better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have end-stage kidney disease and be on maintenance hemodialysis (regular dialysis).
- You cannot have an acute kidney injury or rapidly worsening kidney inflammation.
- You cannot have an active infection or inflammatory condition like sepsis or autoimmune disease.
- You must not have liver cirrhosis (severe scarring) or certain gut problems.
- You must not have had an organ transplant (except possibly kidney, if enough patients join).
- You cannot be pregnant, breastfeeding, or have cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if zinc levels in the blood are linked to lupus nephritis. It may help doctors understand how zinc affects kidney health in people with lupus.
This study looks at whether zinc levels in the blood are linked to how severe diabetic kidney disease is. It could help doctors better understand and manage kidney problems in people with diabetes.
This trial tests whether taking copper supplements can help people with cirrhosis (scarring of the liver) who have low copper levels or symptoms related to copper deficiency. It aims to see if this can improve their health.
This study is looking at what happens to copper levels in the urine when people with Wilson disease briefly stop their medicine. It may help doctors understand how well your body controls copper without treatment.
This trial tests whether zinc supplements can lower high homocysteine levels better than folic acid in people with chronic kidney disease who are on hemodialysis. It aims to find a simple, safe way to help protect your heart and blood vessels.
This trial tests whether taking zinc supplements can improve the outlook for people with a certain type of advanced liver disease that is still stable (no major complications). If you have compensated advanced chronic liver disease and meet the criteria, you might be able to join.
Hear when a new Control Condition trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.